SCAMP5 Antibody [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NB120-3432G
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Rat
Applications
Western Blot
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Synthetic Peptide: C N(217) Q P Q T Q Y S A T P N Y T Y S N(233)
Reactivity Notes
Expected cross-reactivity with Mouse base on sequence identity.
Specificity
NB120-3432 immunizing peptide corresponds to amino acid residues 217-233 from rat SCAMP 5. This sequence is 94% conserved in mouse.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for SCAMP5 Antibody [DyLight 488]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SCAMP5
Alternate Names
DKFZp686L1799, hSCAMP5, MGC24969, Sc5, secretory carrier membrane protein 5, secretory carrier-associated membrane protein 5
Gene Symbol
SCAMP5
Additional SCAMP5 Products
Product Documents for SCAMP5 Antibody [DyLight 488]
Product Specific Notices for SCAMP5 Antibody [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...